Several cancers lead to tumors which can no longer be removed by surgery anymore due to how much they have invade, their location in the body, and how much extra risk it provides to the patient. Many of these cancers, like late stage liver cancer, have very poor survival rates because chemotherapy and radiation are not enough to take down those large tumors.

Using glucose as a power source, our enzyme-loaded microscopic capsules will deplete oxygen and glucose from the cancer immediately after injection. This is possible through our patented formulation that allows unprecedented quantities of enzymes to be stabilized within a microscale volume. The contents of HypoxyCaps are non-toxic and environmentally friendly, and biodegradable so they won’t stick around in the body longer than needed.

While standard embolization beads without enzymes are currently used to treat 40% of liver cancers, the addition of our enzymes to HypoxyCaps extend their effectiveness zone, providing high efficacy and longer survival.

Learn more about our technology here: https://www.pnas.org/doi/abs/10.1073/pnas.2217557120